Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03821103 · ClinicalTrials.gov registry record · NA

Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
104
Enrollment target

NCT03821103: Completed NA study, sponsored by University of Pennsylvania.

NCT03821103 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03821103, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
104 participants
Enrollment target

Study Summary

This study seeks to test standard and behavioral economic-enhanced training strategies to bolster first-time Emergency Department-initiated buprenorphine-naloxone administration among Emergency Department providers.

Interventions

  • BEHAVIORAL Training
  • BEHAVIORAL Behavioral economic enhanced arm

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2019-02-06
Est. Completion 2020-02-29
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT03821103

The ClinicalTrials.gov registry entry for NCT03821103 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Training is the first listed.

NCT03821103 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03821103 about?

NCT03821103 is a clinical study titled "Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments". This study seeks to test standard and behavioral economic-enhanced training strategies to bolster first-time Emergency Department-initiated buprenorphine-naloxone administration among Emergency Department providers.

What is the current status of trial NCT03821103?

This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2019-02-06. Estimated completion is 2020-02-29.

What interventions are being tested in trial NCT03821103?

The interventions under investigation include: Training (BEHAVIORAL), Behavioral economic enhanced arm (BEHAVIORAL).

Who is sponsoring clinical trial NCT03821103?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.